PL2713776T3 - Kompozycja przeciwutleniaczy do ograniczania przyczyn obniżonej męskiej zdolności rozrodczej - Google Patents

Kompozycja przeciwutleniaczy do ograniczania przyczyn obniżonej męskiej zdolności rozrodczej

Info

Publication number
PL2713776T3
PL2713776T3 PL12735013T PL12735013T PL2713776T3 PL 2713776 T3 PL2713776 T3 PL 2713776T3 PL 12735013 T PL12735013 T PL 12735013T PL 12735013 T PL12735013 T PL 12735013T PL 2713776 T3 PL2713776 T3 PL 2713776T3
Authority
PL
Poland
Prior art keywords
reduction
causes
antioxidant composition
male reproductive
reproductive capacity
Prior art date
Application number
PL12735013T
Other languages
English (en)
Inventor
Vittorio Unfer
Original Assignee
Lo Li Pharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lo Li Pharma Srl filed Critical Lo Li Pharma Srl
Publication of PL2713776T3 publication Critical patent/PL2713776T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL12735013T 2011-06-03 2012-06-01 Kompozycja przeciwutleniaczy do ograniczania przyczyn obniżonej męskiej zdolności rozrodczej PL2713776T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001010A ITMI20111010A1 (it) 2011-06-03 2011-06-03 Composizione antiossidante, particolarmente per la riduzione delle cause della ridotta capacita' riproduttiva maschile.
PCT/IB2012/052770 WO2012164535A1 (en) 2011-06-03 2012-06-01 Antioxidant composition for the reduction of the causes of reduced male reproductive capacity
EP12735013.0A EP2713776B1 (en) 2011-06-03 2012-06-01 Antioxidant composition for the reduction of the causes of reduced male reproductive capacity

Publications (1)

Publication Number Publication Date
PL2713776T3 true PL2713776T3 (pl) 2015-12-31

Family

ID=44554930

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12735013T PL2713776T3 (pl) 2011-06-03 2012-06-01 Kompozycja przeciwutleniaczy do ograniczania przyczyn obniżonej męskiej zdolności rozrodczej

Country Status (7)

Country Link
EP (1) EP2713776B1 (pl)
DK (1) DK2713776T3 (pl)
ES (1) ES2550338T3 (pl)
HU (1) HUE027991T2 (pl)
IT (1) ITMI20111010A1 (pl)
PL (1) PL2713776T3 (pl)
WO (1) WO2012164535A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104721184B (zh) * 2015-02-16 2017-05-10 中国农业大学 一种提高奶牛受胎率的制剂及其制备方法与应用
RU2619330C1 (ru) * 2016-03-24 2017-05-15 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии и регенеративной медицины имени Е.Д. Гольдберга" Средство для профилактики и лечения патозооспермии
IT201600115036A1 (it) * 2016-11-15 2018-05-15 Lta Biotech S R L Metodo per la diagnosi in vitro di infertilità maschile.
WO2019239268A1 (en) * 2018-06-15 2019-12-19 Angelo Chieregati Composition for the treatment of infertility
RU2717240C1 (ru) * 2019-06-05 2020-03-19 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Средство для коррекции отдаленных последствий нарушений сперматогенеза, вызванных цитостатическим воздействием
IT202200010592A1 (it) * 2022-05-23 2023-11-23 Neilos S R L “Composizione nutraceutica o farmaceutica per l’infertilità maschile”

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922704A (en) * 1997-12-24 1999-07-13 Feeling Fine Company Llc Optimal nutritional supplement for men
US20050142124A1 (en) * 2003-12-31 2005-06-30 Kaiser Jon D. Nutrient compositions and methods for enhanced effectiveness of the immune system
US7438933B2 (en) * 2004-12-09 2008-10-21 The Board Of Trustees Of The University Of Arkansas System Maternal multi-nutrient against diabetes-related birth defects
DE202008016372U1 (de) * 2008-12-11 2009-04-16 Orthomol Pharmazeutische Vertriebs Gmbh Vitamin enthaltende Zusammensetzung

Also Published As

Publication number Publication date
ES2550338T3 (es) 2015-11-06
WO2012164535A1 (en) 2012-12-06
HUE027991T2 (en) 2016-11-28
EP2713776A1 (en) 2014-04-09
EP2713776B1 (en) 2015-07-22
ITMI20111010A1 (it) 2012-12-04
DK2713776T3 (en) 2015-10-26

Similar Documents

Publication Publication Date Title
HK1215161A1 (zh) 表面活性劑體系用於含鋅組合物
HK1200658A1 (en) Nutritional phytonutrient compositions
HK1192375A1 (zh) 串聯多叉壓入式插頭
ZA201402148B (en) Coolant formulations
GB2502032B (en) Stable Vitamin D3 Composition
EP2704701A4 (en) COMPOUNDS FOR USE AGAINST INFLAMMATORY AND IMMUNOMIC DISEASES
SI2753311T1 (sl) Formulacije antioksidanta
EP3077407A4 (en) Compounds and compositions for imaging gcc-expressing cells
PL2713776T3 (pl) Kompozycja przeciwutleniaczy do ograniczania przyczyn obniżonej męskiej zdolności rozrodczej
HUE048512T2 (hu) Kompozíció kandidiázis megelõzésére
HRP20180587T1 (hr) Pripravak krutog surfaktanta
EP2768481A4 (en) COMPOSITIONS TO REDUCE SIDE EFFECTS
EP2741733A4 (en) TOPICAL ANTI-OXIDANT COMPOSITIONS
RS58781B1 (sr) Kompozicije i postupci za redukciju reproduktivnog kapaciteta ženki pacova
AP2013006693A0 (en) Phamaceutical composition for the prolonged release of trimetazidine
ZA201209708B (en) Synergistic antioxidant composition
ZA201308990B (en) Methods for increasing the palatability of food compositions
HK1212206A1 (en) Compositions for immunotherapy
GB201102162D0 (en) Contraceptive compounds
IL222808A0 (en) Synergistic antioxidant composition
AU342498S (en) Spanner